Alpha Tau Medical

Alpha Tau Medical is a pioneering biotechnology research company dedicated to the research, development, and commercialization of Alpha DaRT (Diffusing Alpha-Emitters Radiation Therapy) for the treatment of solid cancer tumors. Originally developed at Tel Aviv University, Alpha DaRT has demonstrated both effectiveness and safety in treating various types of cancer through extensive animal studies. The company is actively conducting clinical trials at numerous leading cancer centers worldwide, including sites in the EU. Alpha Tau Medical is committed to innovation in cancer treatment, striving to provide advanced solutions for patients globally.

Alpha Tau Medical's groundbreaking Alpha DaRT technology delivers high-precision alpha radiation to all types of solid tumors. This innovative treatment involves the insertion of Radium-224 impregnated seeds directly into the tumor. As the Radium decays, its short-lived daughters are released, dispersing within the tumor and emitting high-energy alpha particles to destroy cancerous cells. With minimal diffusion into healthy tissue, Alpha DaRT primarily targets the tumor, preserving the surrounding healthy tissue. Alpha Tau Medical operates from its primary address at Kiryat HaMada St 5, Jerusalem, 9777605, IL, and also maintains a presence at 1 Union St., Lawrence, Massachusetts 01840, US.

Alpha Tau Medical continues to advance cancer therapy with its innovative technology and ongoing clinical trials. The company's mission is to improve patient outcomes and quality of life through effective and targeted cancer treatments. To discover more about Alpha Tau Medical and its groundbreaking work, we invite you to visit their website. We encourage the manager of Alpha Tau Medical to create a customized and exclusive company showcase and product listing on our platform to further enhance their commercial development.